New board member will serve as a visionary for the company as it moves forward with new innovations in medical data, artificial intelligence, and telemedicine.
Transcatheter structural heart therapies stand to replace their open-heart counterparts thanks to technological innovations and expanded patient access.
In 2019, I had to take a long, hard look at both my businesses and my industry to find balance and a way forward through the ripple effects of big changes.
Dawn A. Lissy, President & Founder, Empirical01.29.20